Radiofrequency skin tightening is not new. The technology has existed in clinical settings for decades, and its mechanism is well understood: controlled thermal energy delivered to the dermis stimulates fibroblast activity, triggers collagen and elastin production and progressively firms the skin. Used correctly, it remains one of the most effective non-invasive treatments available. The problem is not the technology. The problem is the hype cycle that surrounds it, the frequency with which new devices are marketed as revolutionary, and the gap between what practitioners promise and what patients understand about the risks.
XERF, Morpheus8 and HIFU are currently the three most searched non-surgical tightening treatments. Each has genuine clinical applications. Each, in the wrong hands or at inappropriate settings, carries risks that are rarely discussed in the consultation room. Fatma Shaheen, who has been performing multipolar radiofrequency treatments for 18 years and has treated patients presenting with complications from all three devices, believes the conversation needs to change.
"I have seen what happens when faces follow hype. The damage does not always appear immediately. When it does, patients do not connect it to the treatment they had. They think their skin is ageing faster. They think they need more. That is the most dangerous part of all."
Dual-frequency monopolar RF targeting the SMAS layer
XERF is an FDA-cleared non-surgical skin tightening treatment using dual-frequency monopolar radiofrequency at 6.78 MHz and 2 MHz. It is designed to penetrate the dermis and reach the SMAS layer the fibromuscular layer that sits beneath the facial fat and above the muscle, the same structure surgeons access in a traditional facelift. By targeting this depth, XERF aims to stimulate collagen production, tighten sagging skin, reduce jowls and lift the lower face with minimal pain and little clinical downtime.
The marketing is compelling and the FDA clearance lends legitimacy. Results in controlled clinical settings can be significant. But monopolar radiofrequency, by its nature, concentrates thermal energy along a single pathway from the skin's surface down to its target depth. To reach the SMAS layer, that energy passes through the subcutaneous fat layer of the face. That is where the risk begins.
Fractional RF microneedling with deep tissue penetration
Morpheus8 combines microneedling with monopolar radiofrequency energy, delivering heat to a depth of up to 8mm via insulated needles. It is positioned as a treatment for skin laxity, textural improvement, acne scarring and facial contouring. The fractional delivery means it treats a percentage of the skin's surface at each session, leaving surrounding tissue intact to support healing.
At appropriate depths and energy settings, Morpheus8 produces measurable collagen remodelling and skin tightening. The concern arises with the depth of energy delivery. At 8mm, Morpheus8 is reaching into the subcutaneous fat layer in many areas of the face, particularly in patients with less facial volume or in zones where fat pads are naturally thin. Repeated treatments at high energy settings create a cumulative thermal effect that can progressively damage fat cells over time, with the consequences appearing months or even years after treatment.
High-intensity focused ultrasound and the SMAS layer
High-intensity focused ultrasound, most widely known through the Ultherapy device, was among the first non-invasive technologies to target the SMAS layer. It uses focused ultrasound energy to create precise thermal injury points at specific depths, stimulating a wound-healing response that produces new collagen. The treatment became enormously popular and remains widely available.
HIFU carries the same fundamental risk as the monopolar RF devices: focused high-intensity energy delivered to deep tissue levels passes through or targets structures adjacent to facial fat pads. Overcautious practitioners often stack treatments or use higher intensities to satisfy patients seeking more dramatic results. The outcome, frequently observed in clinical practice, is progressive hollowing of the cheeks, temples and periorbital area volume loss that is permanent, that reads as accelerated ageing, and that sends patients back to clinics seeking further treatments that compound the original damage.
Volume is not the enemy. It is the structure.
The facial fat pads are architectural. They are what create the rounded, lifted contours of youthful skin the fullness of the cheeks, the smooth transition from under-eye to cheekbone, the definition of the temples. They are not excess. They are structure. When monopolar or high-intensity energy devices damage fat cells through repeated or aggressive heat delivery, those cells do not regenerate. The loss is permanent.
The clinical presentation is distinctive: initially the patient may appear more defined and lifted, as skin tightens over a reduced fat volume. Within months, however, the hollowing becomes apparent. The cheeks flatten. The temples sink. The under-eye area deepens. The nasolabial folds become more pronounced as the supporting fat beneath them diminishes. The face does not look younger. It looks depleted.
Patients presenting with unexplained facial hollowing, accelerated volume loss or structural facial changes following multiple skin tightening treatments are a consistent pattern in clinical practice. In the majority of cases, they have undergone repeated monopolar RF, Morpheus8 or HIFU treatments, often at multiple clinics, often chasing results that were satisfying initially but appeared to diminish over time.
What they describe as accelerated ageing is, in most cases, treatment-induced fat atrophy. They do not make the connection because the change is gradual and because no practitioner has told them it is possible. Many have continued booking further treatments, believing more is required. Each session contributes to the cumulative loss.
This is the part of the conversation that the industry is not having loudly enough.
Where energy goes is everything
The distinction between monopolar and multipolar radiofrequency is not a matter of degree. It is a matter of physics, and the physics has direct clinical consequences.
Monopolar radiofrequency uses a single active electrode on the skin and a grounding pad placed elsewhere on the body. The electrical current travels from the surface electrode through the tissue to the ground pad, concentrating thermal energy along that pathway. The depth of penetration is significant, which is why monopolar devices can reach the SMAS layer. That same depth and concentration is what creates the risk of fat atrophy in tissues the current passes through on the way to its target.
Multipolar radiofrequency uses multiple electrodes simultaneously, passing current between poles in a controlled pattern across a defined treatment area. The energy is distributed across multiple tissue depths rather than concentrated along a single pathway. The thermal effect is more diffuse, more controlled, and critically, it does not concentrate at the fat layer in the same way. The dermis is stimulated. Collagen and elastin production is triggered. The structural fat beneath is preserved.
Monopolar RF
Single active electrode. Current travels deep through tissue to a grounding pad. High concentration of thermal energy along one pathway. Reaches SMAS layer. Risk of fat atrophy with repeated use or high settings. Includes: XERF, some Morpheus8 modes, older HIFU-adjacent devices.
Multipolar RF
Multiple electrodes. Current distributed between poles across the treatment area. Diffuse, controlled thermal energy across multiple tissue depths. Stimulates dermis and collagen production. Preserves subcutaneous fat layer. Lower risk profile. Suitable for repeated clinical use.
Why multipolar remains the gold standard
Fatma Shaheen has used multipolar radiofrequency as the foundation of the SDL Clinic's tightening protocols since the clinic's inception. The choice was not made by default. It was made after extensive clinical observation of what different RF technologies do to skin and underlying tissue over time, across different skin types, ages and facial structures.
Multipolar RF consistently delivers progressive, structural skin tightening. It stimulates fibroblast activity and collagen synthesis in the dermis. It improves skin density, firmness and elasticity over a course of treatments. It does so without the risk of fat atrophy because the energy distribution does not concentrate thermal damage in the subcutaneous layer. It is the technology that Shaheen trusts on clients who cannot afford complications the A-list clients, the red carpet faces, the clients who need visible results without a single day of unintended change.
After 18 years, with thousands of treatments performed and a consistent clinical record, that position has not changed. New devices arrive. Some have genuine merit in specific clinical contexts. None has produced the combination of safety, consistency and progressive structural results that multipolar RF delivers when applied with clinical precision and the right protocol.
Informed consent means understanding the risks
Any practitioner offering XERF, Morpheus8, HIFU or any high-intensity tightening treatment should be prepared to answer the following questions clearly and without defensiveness. If they cannot or will not, that is clinically significant information.
What is the depth of energy delivery for this treatment on my face, and what tissue layers does that include? What is the risk of subcutaneous fat atrophy with this device, and how does that risk change with repeated treatments? How many treatments are you recommending, at what interval, and what is the clinical rationale for that frequency? Have you treated patients who experienced volume loss following this treatment, and how did you manage it? What is your assessment of my current facial fat volume and structure, and how does that inform the settings you would use?
A practitioner who has genuinely considered the risk profile of the device they are using will answer these questions with clinical specificity. A practitioner who leads with before and after photographs and treatment packages is not the right person to deliver a treatment that reaches the SMAS layer of your face.
Structural tightening without structural compromise
The TIGHTEN PRO treatment at the SDL Clinic uses multipolar radiofrequency as its core tightening technology, combined with precision lymphatic cupping and sculpting protocol. The multipolar RF stimulates collagen and elastin production in the dermis, progressively firming the skin and restoring structural density without the fat atrophy risk associated with monopolar devices. Lymphatic cupping ensures optimal circulation, removes fluid stagnation and primes the tissue for maximum clinical response.
Every TIGHTEN PRO treatment is preceded by a clinical skin assessment. Settings are calibrated to the individual, with specific attention to facial volume, skin thickness and treatment history. Patients with a history of monopolar RF, Morpheus8 or HIFU treatments receive a dedicated evaluation before any SDL treatment is planned. The protocol is designed to deliver progressive, visible, safe results. Not a single dramatic session with an unpredictable aftermath. A clinical sequence with a consistent, measurable outcome.
Fatma Shaheen is now in residence at 40 Duke Street, the private members club at Selfridges, London, where the full SDL treatment protocol including the TIGHTEN PRO is available by appointment.
"Skin tightening technology works. The question is which technology, at what depth, in whose hands, and how many times. Those are clinical decisions. They should be made by clinicians, not by trend cycles."